Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dopamine | 20 | 2004 | 276 | 1.730 |
Why?
|
| Neurons | 17 | 2004 | 1584 | 1.250 |
Why?
|
| Mesencephalon | 10 | 2004 | 64 | 1.010 |
Why?
|
| Methamphetamine | 7 | 2002 | 87 | 0.920 |
Why?
|
| Corpus Striatum | 9 | 2003 | 88 | 0.580 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2002 | 158 | 0.520 |
Why?
|
| Nerve Tissue Proteins | 4 | 2001 | 512 | 0.360 |
Why?
|
| Serotonin | 4 | 2002 | 221 | 0.350 |
Why?
|
| Nerve Growth Factors | 3 | 2000 | 63 | 0.340 |
Why?
|
| Fetus | 5 | 2002 | 232 | 0.330 |
Why?
|
| Hybrid Cells | 6 | 2003 | 71 | 0.320 |
Why?
|
| Neurotoxins | 2 | 2001 | 49 | 0.320 |
Why?
|
| Tyrosine 3-Monooxygenase | 6 | 1997 | 44 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 16 | 2002 | 3225 | 0.290 |
Why?
|
| Substantia Nigra | 3 | 2001 | 28 | 0.280 |
Why?
|
| Mice | 24 | 2004 | 11792 | 0.280 |
Why?
|
| Brain | 4 | 2002 | 2289 | 0.280 |
Why?
|
| Serotonin Agents | 2 | 2002 | 12 | 0.240 |
Why?
|
| Fatty Acids | 1 | 2004 | 134 | 0.230 |
Why?
|
| Growth Substances | 1 | 2003 | 80 | 0.230 |
Why?
|
| Dopamine Agents | 2 | 2001 | 28 | 0.220 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2002 | 72 | 0.220 |
Why?
|
| Animals | 26 | 2004 | 27428 | 0.210 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2001 | 1253 | 0.200 |
Why?
|
| Cell Aggregation | 8 | 2002 | 39 | 0.200 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2002 | 27 | 0.200 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2000 | 121 | 0.190 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2001 | 28 | 0.190 |
Why?
|
| Pregnancy | 8 | 2002 | 3027 | 0.190 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2001 | 44 | 0.190 |
Why?
|
| Cerebellum | 3 | 2000 | 249 | 0.180 |
Why?
|
| Heterozygote | 2 | 1998 | 373 | 0.180 |
Why?
|
| Immunohistochemistry | 8 | 2003 | 1801 | 0.180 |
Why?
|
| Membrane Transport Proteins | 1 | 2001 | 169 | 0.180 |
Why?
|
| Potassium Channels | 2 | 2000 | 343 | 0.170 |
Why?
|
| Cell Line | 6 | 2004 | 2496 | 0.170 |
Why?
|
| Up-Regulation | 1 | 2002 | 728 | 0.160 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 432 | 0.160 |
Why?
|
| Embryonic and Fetal Development | 2 | 1997 | 72 | 0.160 |
Why?
|
| Potassium | 2 | 2000 | 255 | 0.160 |
Why?
|
| Culture Techniques | 6 | 1995 | 91 | 0.160 |
Why?
|
| Axons | 2 | 1997 | 181 | 0.160 |
Why?
|
| Cells, Cultured | 10 | 2002 | 2884 | 0.150 |
Why?
|
| Cell Count | 4 | 2002 | 200 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2001 | 1100 | 0.140 |
Why?
|
| Neostriatum | 3 | 2001 | 26 | 0.130 |
Why?
|
| Acetylcholinesterase | 2 | 1995 | 48 | 0.130 |
Why?
|
| Receptors, Dopamine | 1 | 1995 | 37 | 0.120 |
Why?
|
| Acetylcholine | 1 | 1995 | 177 | 0.120 |
Why?
|
| Models, Biological | 1 | 2001 | 1767 | 0.110 |
Why?
|
| Cytological Techniques | 1 | 1993 | 30 | 0.110 |
Why?
|
| Phosphoproteins | 2 | 1995 | 261 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2004 | 1944 | 0.100 |
Why?
|
| Brain Chemistry | 3 | 2001 | 122 | 0.090 |
Why?
|
| Mice, Neurologic Mutants | 3 | 2000 | 18 | 0.090 |
Why?
|
| Cell Survival | 4 | 2003 | 983 | 0.080 |
Why?
|
| Female | 10 | 2002 | 46361 | 0.080 |
Why?
|
| Synapses | 1 | 1989 | 280 | 0.070 |
Why?
|
| Embryo, Mammalian | 3 | 1992 | 223 | 0.070 |
Why?
|
| Time Factors | 5 | 2004 | 5344 | 0.070 |
Why?
|
| Oleic Acid | 1 | 2004 | 15 | 0.060 |
Why?
|
| Oleic Acids | 1 | 2004 | 26 | 0.060 |
Why?
|
| Calcium | 2 | 2000 | 1177 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 314 | 0.060 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 2 | 1995 | 6 | 0.050 |
Why?
|
| Litter Size | 1 | 2002 | 13 | 0.050 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 2 | 2000 | 8 | 0.050 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2002 | 12 | 0.050 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2002 | 26 | 0.050 |
Why?
|
| Homovanillic Acid | 1 | 2002 | 35 | 0.050 |
Why?
|
| Biogenic Monoamines | 1 | 2001 | 9 | 0.050 |
Why?
|
| Weight Gain | 1 | 2002 | 119 | 0.050 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2001 | 36 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2001 | 125 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2001 | 293 | 0.050 |
Why?
|
| Fever | 1 | 2001 | 128 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2000 | 21 | 0.050 |
Why?
|
| Brain Stem | 1 | 2001 | 167 | 0.050 |
Why?
|
| Glutathione | 1 | 2000 | 108 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2002 | 345 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2001 | 327 | 0.040 |
Why?
|
| Septal Nuclei | 2 | 1989 | 9 | 0.040 |
Why?
|
| Parkinson Disease | 1 | 2000 | 150 | 0.040 |
Why?
|
| Cholinergic Fibers | 2 | 1989 | 24 | 0.040 |
Why?
|
| Kinetics | 1 | 2001 | 1530 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2000 | 319 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 1998 | 154 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2001 | 681 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 589 | 0.040 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 1996 | 7 | 0.030 |
Why?
|
| Catecholamines | 2 | 2000 | 92 | 0.030 |
Why?
|
| Neuronal Plasticity | 2 | 1989 | 194 | 0.030 |
Why?
|
| Linear Models | 1 | 1997 | 421 | 0.030 |
Why?
|
| Appetite Depressants | 1 | 1995 | 11 | 0.030 |
Why?
|
| Choline O-Acetyltransferase | 2 | 1992 | 23 | 0.030 |
Why?
|
| Fenfluramine | 1 | 1995 | 20 | 0.030 |
Why?
|
| Hippocampus | 2 | 1989 | 448 | 0.030 |
Why?
|
| Calibration | 1 | 1995 | 103 | 0.030 |
Why?
|
| Adenylyl Cyclases | 1 | 1995 | 100 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 1995 | 195 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 1057 | 0.030 |
Why?
|
| Fluorescence | 1 | 1993 | 103 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 1995 | 219 | 0.030 |
Why?
|
| Genotype | 1 | 1997 | 1852 | 0.030 |
Why?
|
| Binding Sites | 1 | 1995 | 1118 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1989 | 511 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1992 | 273 | 0.020 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 1991 | 12 | 0.020 |
Why?
|
| Neurofilament Proteins | 1 | 1991 | 14 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1991 | 130 | 0.020 |
Why?
|
| Cell Fusion | 1 | 1991 | 39 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1991 | 59 | 0.020 |
Why?
|
| PC12 Cells | 1 | 1991 | 115 | 0.020 |
Why?
|
| Clone Cells | 1 | 1991 | 214 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1992 | 432 | 0.020 |
Why?
|
| Base Sequence | 1 | 1995 | 2329 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1991 | 323 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 1993 | 783 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 3027 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 1991 | 436 | 0.020 |
Why?
|
| Tegmentum Mesencephali | 1 | 1989 | 12 | 0.020 |
Why?
|
| Immune Sera | 1 | 1989 | 52 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1995 | 2019 | 0.020 |
Why?
|
| Biomarkers | 1 | 1995 | 1770 | 0.020 |
Why?
|
| Cell Communication | 1 | 1988 | 200 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1991 | 399 | 0.020 |
Why?
|
| Buthionine Sulfoximine | 1 | 2000 | 7 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2000 | 63 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 2000 | 83 | 0.010 |
Why?
|
| Neuroglia | 1 | 2000 | 105 | 0.010 |
Why?
|
| Lidocaine | 1 | 2000 | 65 | 0.010 |
Why?
|
| Potassium Channel Blockers | 1 | 2000 | 64 | 0.010 |
Why?
|
| Homozygote | 1 | 2000 | 204 | 0.010 |
Why?
|
| Humans | 2 | 2000 | 89630 | 0.010 |
Why?
|
| Male | 1 | 2001 | 42561 | 0.010 |
Why?
|
| Superior Colliculi | 1 | 1989 | 23 | 0.010 |
Why?
|